Cheryl Barton is director of PharmaVision, 

Articles

European biotechnology companies are increasing patient access to innovative cell and gene therapies through decentralized next-generation manufacturing platforms. 

European Biotechs Developing Next-Generation Cell and Gene Therapy Manufacturing Technologies

Quantum chemistry is accelerating drug discovery AI by providing physics-based, reproducible, and scalable data that encodes molecular reality.

How Quantum Chemistry Fills the AI Gap

Bristol Myers Squibb collaborates with Anthropic to accelerate drug development, manufacturing quality systems, and regulatory documentation via AI integration.

BMS-Anthropic Signals AI Move in Drug Manufacturing Quality Systems

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

Siegfried Schmitt, PhD, is Vice President Technical at Parexel International, Siegfried.Schmitt@parexel.com.

Videos

Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice on creating a robust out-of-specification procedure. 

Ask the Expert: Enhancing Out-of-Specification Procedures

Sandra Coufal, MD, Toragen, discusses advancing TGNS15 with strong IP, liquid formulation, and an accelerated FDA pathway, potentially saving millions on IND-enabling studies.

How Toragen Is Fast-Tracking TGN-S15 to IND

Nicholas Richardson is vice president of clinical development at Precision for Medicine.

Nicholas Richardson, vice president of clinical development at Precision for Medicine, explains why radiopharmaceuticals are unique for patients with cancer and what makes them challenging to develop for those patients. 

Patient Access to Radiopharmaceuticals, Part 1

Lilly’s Engage Bio acquisition adds a preclinical non-viral DNA delivery platform to its genetic medicines development portfolio.

Lilly Acquires Preclinical Non-Viral DNA Delivery Platform for $202M

Portfolio Manager
Intensified Downstream Systems
Sartorius

Global Technical Product Specialist
Thermo Fisher Scientific

Stuart Tindal, Sartorius, and David Chau, Thermo Fisher, discuss automation, single-use technology limits, and predictive control shaping continuous bioprocessing's future.

Q&A: How Continuous Bioprocessing Is Evolving With Smarter Automation

Sandra Coufal, MD, Toragen, discusses how TGN-S15's preferred enantiomer showed no neurotoxicity and reduced tumor growth, supporting development of the oral cancer drug.

From Bench to Pill: Enantiomer Science and Oral Delivery

Deborah Smook is co-founder and co-owner of TurboFil Packaging Machines.

Deborah Smook, co-founder and co-owner of TurboFil Packaging Machines, explains some of the challenges involved with prefilled syringe manufacturing. 

News